Quarterly Earnings

Riding a wave of record copper prices driven by AI and the energy transition, Trekor Metals reports a stellar quarter, unlocking new value with its innovative Florence mine.

The distributor's Xvantage Integration Hub is more than a tool; it's the core of a new operating system for IT, delivering real ROI and a strategic edge.

NewLake Capital Partners reports stable Q2 results with 100% rent collection, deftly managing tenant restructuring while executing strategic growth.

Fresh out of bankruptcy, Nine Energy Service faces a rocky road. Equipment failures and inflation hit profits, but a booming tech division offers powerful hope.

Ero Copper posts stellar Q2 results, slashing debt with record cash flow. Strategic tech and savvy hedging fuel operational wins and future growth.

AirBoss of America's Q2 results reveal a masterclass in strategy. While profits rise, the real story is how its defense arm thrives amid global chaos.

Valaris reports strong Q2 earnings, but the real story is its resilience against conflict costs and the transformative Transocean merger set to reshape offshore drilling.

With a pill aimed at both heart disease and blindness, BioAge Labs is betting its future on fighting aging itself. Is this the dawn of a new era in medicine?

Fresh off its IPO, National Healthcare Properties reports soaring senior housing profits, a dramatic balance sheet overhaul, and a $400M acquisition spree.

The Gulf producer posts a striking profit and slashes debt, but a potential billion-dollar litigation outcome casts a long shadow over its future.

HMH Holding Inc.'s Q2 results reveal a calculated strategy: using its IPO to fortify its balance sheet while betting on digital tech to outmaneuver market headwinds.

With record revenue, soaring margins, and a surge in client assets, Victory Capital's Q2 results reveal a masterclass in strategic commercialization.

U.S. Physical Therapy's Q2 earnings show a complex picture. Discover how its strategic partnerships are setting the stage for future growth.

The holding company's stunning profit leap, driven by its chemical and components arms, reveals a story of operational grit and a major turnaround.

The TiO2 giant swung from loss to profit, beating estimates. A deep dive into how cost-cutting and market share gains are redefining success in a tough economy.

As Biofrontera preps its Q2 report, investors weigh record revenue and expanded margins against persistent losses and a critical need for cash flow breakeven.

NuScale Power’s revenue vanished in Q2, but its cash hoard swelled to $1.9B. It’s a high-stakes pivot from design fees to a costly industrial reality.

TPVG's Q2 results show a complex picture: strong realized gains from strategic exits, but declining investment income points to a shifting venture debt landscape.

Amid economic volatility, PhenixFIN posts stellar Q3 results, driven by a rising NAV per share, resilient credit quality, and savvy capital management.

Facing the biotech cash crunch, Context Therapeutics shelves one drug to double down on two others, a strategic pivot that secures its future into late 2027.